Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. NSE India Stock Exchange
  5. Sun Pharmaceutical Industries Ltd.
  6. Summary
    SUNPHARMA   INE044A01036

SUN PHARMACEUTICAL INDUSTRIES LTD.

(SUNPHARMA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nse India Stock Exchange
05/10/2021 05/11/2021 05/12/2021 05/14/2021 05/17/2021 Date
698.2(c) 708.1(c) 702.85(c) 691.45(c) 687.15 Last
10 924 222 14 760 511 7 250 661 6 851 035 6 318 234 Volume
+2.76% +1.42% -0.74% -1.62% -0.62% Change
More quotes
Financials
Sales 2021 339 B 4 631 M 4 631 M
Net income 2021 38 366 M 524 M 524 M
Net cash position 2021 58 736 M 802 M 802 M
P/E ratio 2021 36,9x
Yield 2021 0,48%
Sales 2022 375 B 5 127 M 5 127 M
Net income 2022 61 610 M 841 M 841 M
Net cash position 2022 106 B 1 453 M 1 453 M
P/E ratio 2022 26,7x
Yield 2022 0,56%
Capitalization 1 659 B 22 646 M 22 657 M
EV / Sales 2021 4,72x
EV / Sales 2022 4,14x
Nbr of Employees 36 000
Free-Float 82,2%
More Financials
Company
Sun Pharmaceutical Industries Ltd. is one of the Indian leaders of pharmaceutical groups. Net sales break down by family of products as follows: - generic and OTC medicines (94%): for cardiologic, psychiatric, neurological, gastroenterological, diabetic and respiratory diseases treatment; - other (6%) : primarily active pharmaceutical ingredients. At the end of March 2020, the group had 43 production plants... 
Sector
Pharmaceuticals
Calendar
05/27Earnings Release
More about the company
Notations Surperformance© of Sun Pharmaceutical Industries Ltd.
Trading Rating : Investor Rating :
More Ratings
All news about SUN PHARMACEUTICAL INDUSTRIES LTD.
05/10Indian Stocks Maintain Four-Day Winning Streak on Monday; Larsen and Toubro R..
MT
05/10Indian shares settle up as record high commodity prices lift metal stocks
RE
05/10India COVID cases hold close to record highs as calls widen for national lock..
RE
05/09Eli Lilly signs deals to boost supply of COVID-19 treatment in India
RE
05/06Indian Stocks End in Green on Thursday; Bajaj Auto Soars 3%
MT
05/05Indian Stocks Close Higher on Wednesday; Sun Pharma Soars 6%
MT
05/05Banks, pharma lift Indian shares after cenbank unveils relief measures
RE
05/05Banks, pharma lift Indian shares after cenbank unveils relief measures
RE
05/03Glenmark, Alembic, Ipca Invest in ABCD Technologies; Stakes of Dr. Reddy's, O..
MT
04/27Merck taps five Indian drugmakers to expand COVID-19 drug production
RE
04/27MERCK & C  : mpany Enters COVID-19 Licensing Deals With Five Indian Manufacturer..
MT
04/27REFILE-UPDATE 1-Merck taps five Indian drugmakers to expand COVID-19 drug pro..
RE
04/27Merck to Allow 5 India Generics Manufacturers to Make Covid-19 Treatment
DJ
04/26U.S. drugmakers step up supplies as India battles COVID-19 surge
RE
04/09New Record High COVID-19 Cases Weigh Indian Stocks Down; Cilpa Rallies over 5..
MT
More news
News in other languages on SUN PHARMACEUTICAL INDUSTRIES LTD.
04/27MERCK  : cinq accords de licence anti-Covid signés en Inde
04/27Merck ermöglicht indischen Generikaherstellern Zugang zu Covid-19-Kandidaten
02/23Farmacéuticas indias se vuelven locales para terminar con dependencia de Chin..
2020Novartis obtient une décision favorable d'un tribunal US sur Gilenya
2020Novartis begrüsst Entscheidung von US-Gericht zu Gilenya (fingolimod)
More news
Analyst Recommendations on SUN PHARMACEUTICAL INDUSTRIES LTD.
More recommendations
Chart SUN PHARMACEUTICAL INDUSTRIES LTD.
Duration : Period :
Sun Pharmaceutical Industries Ltd. Technical Analysis Chart | SUNPHARMA | INE044A01036 | MarketScreener
Technical analysis trends SUN PHARMACEUTICAL INDUSTRIES LTD.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 31
Average target price 687,77 INR
Last Close Price 691,45 INR
Spread / Highest target 22,9%
Spread / Average Target -0,53%
Spread / Lowest Target -27,7%
EPS Revisions
Managers and Directors
NameTitle
Dilip Shantilal Shanghvi Managing Director & Executive Director
C. S. Muralidharan Chief Financial Officer
Israel Makov Non-Executive Chairman
Atanu Roy SVP & Chief Information Officer
Ashok I. Bhuta Compliance Officer & Senior GM-Secretarial
Sector and Competitors